Join moderator Melissa Middeldorp as she discusses the NEJM article Asundexian versus Apixaban in Patients with Atrial Fibrillation with Christopher C Cheung, MD, MPH and Prashanthan Sanders, MBBS, PhD, FHRS at HRS2024 in Atalnta. This episode is brought to you live from the HRSTV Studio and comes with bonus video footage.

https://www.hrsonline.org/education/TheLead https://www.nejm.org/doi/full/10.1056/NEJMoa2407105

Host Disclosure(s): M. Middeldorp: Nothing to disclose.

 

Contributor Disclosure(s): C. Cheung: Nothing to disclose. P. Sanders: Membership on Advisory Committees: Boston Scientific, Medtronic PLC, Pacemate, CathRx, Research: Abbott, Becton Dickinson, Boston Scientific, CathRx, Medtronic, Pacemate.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör The Lead Podcast presented by Heart Rhythm Society. Innehållet i podden är skapat av The Lead Podcast presented by Heart Rhythm Society och inte av, eller tillsammans med, Poddtoppen.